234 related articles for article (PubMed ID: 16984816)
1. The biology of the Gaucher cell: the cradle of human chitinases.
Bussink AP; van Eijk M; Renkema GH; Aerts JM; Boot RG
Int Rev Cytol; 2006; 252():71-128. PubMed ID: 16984816
[TBL] [Abstract][Full Text] [Related]
2. [Chitotriosidase of human macrophages and mammalian chitinases: biological functions and abnormalities in pathology].
Korolenko TA; Cherkanova MS
Vestn Ross Akad Med Nauk; 2009; (11):39-45. PubMed ID: 20017407
[TBL] [Abstract][Full Text] [Related]
3. Identification and use of biomarkers in Gaucher disease and other lysosomal storage diseases.
Aerts JM; Hollak CE; van Breemen M; Maas M; Groener JE; Boot RG
Acta Paediatr Suppl; 2005 Mar; 94(447):43-6; discussion 37-8. PubMed ID: 15895711
[TBL] [Abstract][Full Text] [Related]
4. Molecular cloning and functional characterization of mouse chitotriosidase.
Zheng T; Rabach M; Chen NY; Rabach L; Hu X; Elias JA; Zhu Z
Gene; 2005 Aug; 357(1):37-46. PubMed ID: 16005164
[TBL] [Abstract][Full Text] [Related]
5. Identification of a novel acidic mammalian chitinase distinct from chitotriosidase.
Boot RG; Blommaart EF; Swart E; Ghauharali-van der Vlugt K; Bijl N; Moe C; Place A; Aerts JM
J Biol Chem; 2001 Mar; 276(9):6770-8. PubMed ID: 11085997
[TBL] [Abstract][Full Text] [Related]
6. Chitinase mRNA levels by quantitative PCR using the single standard DNA: acidic mammalian chitinase is a major transcript in the mouse stomach.
Ohno M; Tsuda K; Sakaguchi M; Sugahara Y; Oyama F
PLoS One; 2012; 7(11):e50381. PubMed ID: 23185612
[TBL] [Abstract][Full Text] [Related]
7. Mass spectrometric quantification of glucosylsphingosine in plasma and urine of type 1 Gaucher patients using an isotope standard.
Mirzaian M; Wisse P; Ferraz MJ; Gold H; Donker-Koopman WE; Verhoek M; Overkleeft HS; Boot RG; Kramer G; Dekker N; Aerts JM
Blood Cells Mol Dis; 2015 Apr; 54(4):307-14. PubMed ID: 25842368
[TBL] [Abstract][Full Text] [Related]
8. Elevated plasma glucosylsphingosine in Gaucher disease: relation to phenotype, storage cell markers, and therapeutic response.
Dekker N; van Dussen L; Hollak CE; Overkleeft H; Scheij S; Ghauharali K; van Breemen MJ; Ferraz MJ; Groener JE; Maas M; Wijburg FA; Speijer D; Tylki-Szymanska A; Mistry PK; Boot RG; Aerts JM
Blood; 2011 Oct; 118(16):e118-27. PubMed ID: 21868580
[TBL] [Abstract][Full Text] [Related]
9. Marked differences in tissue-specific expression of chitinases in mouse and man.
Boot RG; Bussink AP; Verhoek M; de Boer PA; Moorman AF; Aerts JM
J Histochem Cytochem; 2005 Oct; 53(10):1283-92. PubMed ID: 15923370
[TBL] [Abstract][Full Text] [Related]
10. [Plasma chitotriosidase activity in Argentinian patients with Gaucher disease, various lysosomal diseases and other inherited metabolic disorders].
Dodelson de Kremer R; Paschini de Capra A; Angaroni CJ; Giner de Ayala A
Medicina (B Aires); 1997; 57(6):677-84. PubMed ID: 9674188
[TBL] [Abstract][Full Text] [Related]
11. Value of plasma chitotriosidase to assess non-neuronopathic Gaucher disease severity and progression in the era of enzyme replacement therapy.
van Dussen L; Hendriks EJ; Groener JE; Boot RG; Hollak CE; Aerts JM
J Inherit Metab Dis; 2014 Nov; 37(6):991-1001. PubMed ID: 24831585
[TBL] [Abstract][Full Text] [Related]
12. [Comparison and clinical application of two methods for determination of plasma chitotriosidase activity].
Wang Y; Zhang HW; Ye J; Qiu WJ; Han LS; Gu XF
Zhonghua Er Ke Za Zhi; 2012 Nov; 50(11):834-8. PubMed ID: 23302614
[TBL] [Abstract][Full Text] [Related]
13. Marked elevation of the chemokine CCL18/PARC in Gaucher disease: a novel surrogate marker for assessing therapeutic intervention.
Boot RG; Verhoek M; de Fost M; Hollak CE; Maas M; Bleijlevens B; van Breemen MJ; van Meurs M; Boven LA; Laman JD; Moran MT; Cox TM; Aerts JM
Blood; 2004 Jan; 103(1):33-9. PubMed ID: 12969956
[TBL] [Abstract][Full Text] [Related]
14. Chitinases and immunity: Ancestral molecules with new functions.
Di Rosa M; Distefano G; Zorena K; Malaguarnera L
Immunobiology; 2016 Mar; 221(3):399-411. PubMed ID: 26686909
[TBL] [Abstract][Full Text] [Related]
15. Strong induction of members of the chitinase family of proteins in atherosclerosis: chitotriosidase and human cartilage gp-39 expressed in lesion macrophages.
Boot RG; van Achterberg TA; van Aken BE; Renkema GH; Jacobs MJ; Aerts JM; de Vries CJ
Arterioscler Thromb Vasc Biol; 1999 Mar; 19(3):687-94. PubMed ID: 10073974
[TBL] [Abstract][Full Text] [Related]
16. Plasma chitotriosidase activity versus CCL18 level for assessing type I Gaucher disease severity: protocol for a systematic review with meta-analysis of individual participant data.
Raskovalova T; Deegan PB; Yang R; Pavlova E; Stirnemann J; Labarère J; Zimran A; Mistry PK; Berger M
Syst Rev; 2017 Apr; 6(1):87. PubMed ID: 28427477
[TBL] [Abstract][Full Text] [Related]
17. Identification, expression and bioactivity of a chitotriosidase-like homolog in amphioxus: dependence of enzymatic and antifungal activities on the chitin-binding domain.
Xu N; Zhang S
Mol Immunol; 2012 May; 51(1):57-65. PubMed ID: 22425351
[TBL] [Abstract][Full Text] [Related]
18. A complete chitinolytic system in the atherinopsid pike silverside Chirostoma estor: gene expression and activities.
Pohls P; González-Dávalos L; Mora O; Shimada A; Varela-Echavarria A; Toledo-Cuevas EM; Martínez-Palacios CA
J Fish Biol; 2016 Jun; 88(6):2130-43. PubMed ID: 27161769
[TBL] [Abstract][Full Text] [Related]
19. A 20-Year Longitudinal Study of Plasma Chitotriosidase Activity in Treated Gaucher Disease Type 1 and 3 Patients-A Qualitative and Quantitative Approach.
Szymańska-Rożek P; Czartoryska B; Kleinotiene G; Lipiński P; Tylki-Szymańska A; Ługowska A
Biomolecules; 2023 Feb; 13(3):. PubMed ID: 36979371
[TBL] [Abstract][Full Text] [Related]
20. Chitotriosidase is the primary active chitinase in the human lung and is modulated by genotype and smoking habit.
Seibold MA; Donnelly S; Solon M; Innes A; Woodruff PG; Boot RG; Burchard EG; Fahy JV
J Allergy Clin Immunol; 2008 Nov; 122(5):944-950.e3. PubMed ID: 18845328
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
